Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOR-TEST: Tenecteplase vs Alteplase in Acute Ischemic Stroke
NCT01949948Phase 3Completed
- Start
- Sep 2012
- Primary completion
- Dec 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke. Started Sep 2012; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01949948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949948.